National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019

National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019 Publisher Pubmed

Azangoukhyavy M¹ ; Saeedi Moghaddam S¹ ; Rezaei N^{1, 2} ; Esfahani Z¹ ; Rezaei N^{1, 2} ; Azadnajafabad S¹ ; Rashidi MM¹ ; Mohammadi E¹ ; Moghaddam SS¹ ; Abbasikangevari M¹ ; Abbasikangevari Z¹ ; Abolhassani H^{7, 8} ; Ahmadi S⁹ ; Ahmadi A^{10, 11} Show All Authors

Azangoukhyavy M¹
Saeedi Moghaddam S¹
Rezaei N^{1, 2}
Esfahani Z¹
Rezaei N^{1, 2}
Azadnajafabad S¹
Rashidi MM¹
Mohammadi E¹
Moghaddam SS¹
Abbasikangevari M¹
Abbasikangevari Z¹
Abolhassani H^{7, 8}
Ahmadi S⁹
Ahmadi A^{10, 11}
Amini S¹²
Amlashi FI¹³
Anoushirvani AA¹⁴
Arabloo J¹⁵
Athari SS¹⁶
Jafari AA¹⁷
Besharat S¹⁸
Bijani A¹⁹
Daryani A²⁰
Dianatinasab M^{21, 22}
Didehdar M²³
Fatehizadeh A²⁴
Ghamari SH¹
Ghashghaee A²⁵
Goleij P²⁶
Golitaleb M²⁷
Hafezinejad N^{28, 29}
Hajmirzaian A^{30, 31}
Hassanipour S^{32, 33}
Kabir A³⁴
Keramati M³⁵
Khalilov R^{36, 37}
Khayamzadeh M^{38, 39}
Kolahi AA^{40, 41}
Kompani F⁴²
Koohestani HR⁴³
Livani S⁴⁴
Mahjoub S^{45, 46}
Malekpour MR¹
Malih N⁴⁷
Mansouri B⁴⁸
Nasab EM⁴⁹
Mirmoeeni S¹⁷
Mohammadianhafshejani A¹⁰
Mohammadpourhodki R⁵⁰
Momtazmanesh S^{1, 29}
Naghipour M^{32, 33}
Najafi H⁵¹
Nazari J⁵²
Nejadghaderi SA^{1, 53}
Noori M⁵⁴
Nowroozi A²⁹
Kan FP⁵⁵
Pezzani R^{56, 57}
Rafiei S⁵⁸
Raoofi S⁵⁹
Razeghinia MS^{60, 61}
Rezaei M⁶²
Rezaei S^{63, 64}
Rezaei N^{1, 2}
Rezazadehkhadem S¹
Saeedi F⁶⁶
Sahebazzamani M^{67, 68}
Sahebkar A^{69, 70}
Shahabi S⁷¹
Sharifirad J⁷²
Sheikhbahaei S²⁸
Shirkoohi R^{73, 74}
Shobeiri P¹
Valizadeh R⁷⁵
Zare I⁷⁶
Tavangar SM³
Jamshidi H^{4, 30}
Mokdad AH^{5, 6}
Naghavi M^{5, 6}
Farzadfar F^{1, 2}
Larijani B²
Mokdad AH^{5, 6}
Naghavi M^{5, 6}

Source: Scientific Reports Published:2022

Abstract

An updated exploration of the burden of thyroid cancer across a country is always required for making correct decisions. The objective of this study is to present the thyroid cancer burden and attributed burden to the high Body Mass Index (BMI) in Iran at national and sub-national levels from 1990 to 2019. The data was obtained from the GBD 2019 study estimates. To explain the pattern of changes in incidence from 1990 to 2019, decomposition analysis was conducted. Besides, the attribution of high BMI in the thyroid cancer DALYs and deaths were obtained. The age-standardized incidence rate of thyroid cancer was 1.57 (95% UI: 1.33–1.86) in 1990 and increased 131% (53–191) until 2019. The age-standardized prevalence rate of thyroid cancer was 30.19 (18.75–34.55) in 2019 which increased 164% (77–246) from 11.44 (9.38–13.85) in 1990. In 2019, the death rate, and Disability-adjusted life years of thyroid cancer was 0.49 (0.36–0.53), and 13.16 (8.93–14.62), respectively. These numbers also increased since 1990. The DALYs and deaths attributable to high BMI was 1.91 (0.95–3.11) and 0.07 (0.04–0.11), respectively. The thyroid cancer burden and high BMI attributed burden has increased from 1990 to 2019 in Iran. This study and similar studies’ results can be used for accurate resource allocation for efficient management and all potential risks’ modification for thyroid cancer with a cost-conscious view. © 2022, The Author(s).

Related Docs

View other Related Docs

1. Continued Rise in the Incidence of Thyroid Cancer in Iran: True Increase or Overdiagnosis?, Journal of Diabetes and Metabolic Disorders (2025)

2. Burden Assessment of Thyroid Cancer in Iran From 1990 to 2010: Lessons Obtained From Global Burden of Disease Report 2010, Asian Pacific Journal of Cancer Prevention (2015)

3. Global, Regional, and National Burden and Quality of Care Index (Qci) of Thyroid Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990–2017, Cancer Medicine (2021)

Experts (# of related papers)

View all Related Experts

Bagher Larijani (8)

Farshad Farzadfar (7)

Style	Citing Format
MLA	Azangoukhyavy M, et al.. "National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019." Scientific Reports, vol. 12, no. 1, 2022, pp. -.
APA	Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi MM, Mohammadi E, Moghaddam SS, Abbasikangevari M, Abbasikangevari Z, Abolhassani H, Ahmadi S, Ahmadi A, Amini S, Amlashi FI, Anoushirvani AA, Arabloo J, Athari SS, ... Naghavi M (2022). National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019. Scientific Reports, 12(1), -.
Chicago	Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi MM, et al.. "National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019." Scientific Reports 12, no. 1 (2022): -.
Harvard	Azangoukhyavy M et al. (2022) 'National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019', Scientific Reports, 12(1), pp. -.
Vancouver	Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, et al.. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019. Scientific Reports. 2022;12(1):-.
BibTex	@article{ author = {Azangoukhyavy M and Saeedi Moghaddam S and Rezaei N and Esfahani Z and Rezaei N and Azadnajafabad S and Rashidi MM and Mohammadi E and Moghaddam SS and Abbasikangevari M and Abbasikangevari Z and Abolhassani H and Ahmadi S and Ahmadi A and Amini S and Amlashi FI and Anoushirvani AA and Arabloo J and Athari SS and Jafari AA and Besharat S and Bijani A and Daryani A and Dianatinasab M and Didehdar M and Fatehizadeh A and Ghamari SH and Ghashghaee A and Goleij P and Golitaleb M and Hafezinejad N and Hajmirzaian A and Hassanipour S and Kabir A and Keramati M and Khalilov R and Khayamzadeh M and Kolahi AA and Kompani F and Koohestani HR and Livani S and Mahjoub S and Malekpour MR and Malih N and Mansouri B and Nasab EM and Mirmoeeni S and Mohammadianhafshejani A and Mohammadpourhodki R and Momtazmanesh S and Naghipour M and Najafi H and Nazari J and Nejadghaderi SA and Noori M and Nowroozi A and Kan FP and Pezzani R and Rafiei S and Raoofi S and Razeghinia MS and Rezaei M and Rezaei S and Rezaei N and Rezazadehkhadem S and Saeedi F and Sahebazzamani M and Sahebkar A and Shahabi S and Sharifirad J and Sheikhbahaei S and Shirkoohi R and Shobeiri P and Valizadeh R and Zare I and Tavangar SM and Jamshidi H and Mokdad AH and Naghavi M and Farzadfar F and Larijani B and Mokdad AH and Naghavi M}, title = {National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Azangoukhyavy M AU - Saeedi Moghaddam S AU - Rezaei N AU - Esfahani Z AU - Rezaei N AU - Azadnajafabad S AU - Rashidi MM AU - Mohammadi E AU - Moghaddam SS AU - Abbasikangevari M AU - Abbasikangevari Z AU - Abolhassani H AU - Ahmadi S AU - Ahmadi A AU - Amini S AU - Amlashi FI AU - Anoushirvani AA AU - Arabloo J AU - Athari SS AU - Jafari AA AU - Besharat S AU - Bijani A AU - Daryani A AU - Dianatinasab M AU - Didehdar M AU - Fatehizadeh A AU - Ghamari SH AU - Ghashghaee A AU - Goleij P AU - Golitaleb M AU - Hafezinejad N AU - Hajmirzaian A AU - Hassanipour S AU - Kabir A AU - Keramati M AU - Khalilov R AU - Khayamzadeh M AU - Kolahi AA AU - Kompani F AU - Koohestani HR AU - Livani S AU - Mahjoub S AU - Malekpour MR AU - Malih N AU - Mansouri B AU - Nasab EM AU - Mirmoeeni S AU - Mohammadianhafshejani A AU - Mohammadpourhodki R AU - Momtazmanesh S AU - Naghipour M AU - Najafi H AU - Nazari J AU - Nejadghaderi SA AU - Noori M AU - Nowroozi A AU - Kan FP AU - Pezzani R AU - Rafiei S AU - Raoofi S AU - Razeghinia MS AU - Rezaei M AU - Rezaei S AU - Rezaei N AU - Rezazadehkhadem S AU - Saeedi F AU - Sahebazzamani M AU - Sahebkar A AU - Shahabi S AU - Sharifirad J AU - Sheikhbahaei S AU - Shirkoohi R AU - Shobeiri P AU - Valizadeh R AU - Zare I AU - Tavangar SM AU - Jamshidi H AU - Mokdad AH AU - Naghavi M AU - Farzadfar F AU - Larijani B AU - Mokdad AH AU - Naghavi M TI - National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019 JO - Scientific Reports VL - 12 IS - 1 SP - EP - PY - 2022 ER -

Style

Citing Format

MLA

Azangoukhyavy M, et al.. "National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019." Scientific Reports, vol. 12, no. 1, 2022, pp. -.

APA

Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi MM, Mohammadi E, Moghaddam SS, Abbasikangevari M, Abbasikangevari Z, Abolhassani H, Ahmadi S, Ahmadi A, Amini S, Amlashi FI, Anoushirvani AA, Arabloo J, Athari SS, ... Naghavi M (2022). National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019. Scientific Reports, 12(1), -.

Chicago

Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi MM, et al.. "National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019." Scientific Reports 12, no. 1 (2022): -.

Harvard

Azangoukhyavy M et al. (2022) 'National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019', Scientific Reports, 12(1), pp. -.

Vancouver

Azangoukhyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, et al.. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019. Scientific Reports. 2022;12(1):-.

BibTex

@article{ author = {Azangoukhyavy M and Saeedi Moghaddam S and Rezaei N and Esfahani Z and Rezaei N and Azadnajafabad S and Rashidi MM and Mohammadi E and Moghaddam SS and Abbasikangevari M and Abbasikangevari Z and Abolhassani H and Ahmadi S and Ahmadi A and Amini S and Amlashi FI and Anoushirvani AA and Arabloo J and Athari SS and Jafari AA and Besharat S and Bijani A and Daryani A and Dianatinasab M and Didehdar M and Fatehizadeh A and Ghamari SH and Ghashghaee A and Goleij P and Golitaleb M and Hafezinejad N and Hajmirzaian A and Hassanipour S and Kabir A and Keramati M and Khalilov R and Khayamzadeh M and Kolahi AA and Kompani F and Koohestani HR and Livani S and Mahjoub S and Malekpour MR and Malih N and Mansouri B and Nasab EM and Mirmoeeni S and Mohammadianhafshejani A and Mohammadpourhodki R and Momtazmanesh S and Naghipour M and Najafi H and Nazari J and Nejadghaderi SA and Noori M and Nowroozi A and Kan FP and Pezzani R and Rafiei S and Raoofi S and Razeghinia MS and Rezaei M and Rezaei S and Rezaei N and Rezazadehkhadem S and Saeedi F and Sahebazzamani M and Sahebkar A and Shahabi S and Sharifirad J and Sheikhbahaei S and Shirkoohi R and Shobeiri P and Valizadeh R and Zare I and Tavangar SM and Jamshidi H and Mokdad AH and Naghavi M and Farzadfar F and Larijani B and Mokdad AH and Naghavi M}, title = {National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }

RIS

TY - JOUR
AU - Azangoukhyavy M
AU - Saeedi Moghaddam S
AU - Rezaei N
AU - Esfahani Z
AU - Rezaei N
AU - Azadnajafabad S
AU - Rashidi MM
AU - Mohammadi E
AU - Moghaddam SS
AU - Abbasikangevari M
AU - Abbasikangevari Z
AU - Abolhassani H
AU - Ahmadi S
AU - Ahmadi A
AU - Amini S
AU - Amlashi FI
AU - Anoushirvani AA
AU - Arabloo J
AU - Athari SS
AU - Jafari AA
AU - Besharat S
AU - Bijani A
AU - Daryani A
AU - Dianatinasab M
AU - Didehdar M
AU - Fatehizadeh A
AU - Ghamari SH
AU - Ghashghaee A
AU - Goleij P
AU - Golitaleb M
AU - Hafezinejad N
AU - Hajmirzaian A
AU - Hassanipour S
AU - Kabir A
AU - Keramati M
AU - Khalilov R
AU - Khayamzadeh M
AU - Kolahi AA
AU - Kompani F
AU - Koohestani HR
AU - Livani S
AU - Mahjoub S
AU - Malekpour MR
AU - Malih N
AU - Mansouri B
AU - Nasab EM
AU - Mirmoeeni S
AU - Mohammadianhafshejani A
AU - Mohammadpourhodki R
AU - Momtazmanesh S
AU - Naghipour M
AU - Najafi H
AU - Nazari J
AU - Nejadghaderi SA
AU - Noori M
AU - Nowroozi A
AU - Kan FP
AU - Pezzani R
AU - Rafiei S
AU - Raoofi S
AU - Razeghinia MS
AU - Rezaei M
AU - Rezaei S
AU - Rezaei N
AU - Rezazadehkhadem S
AU - Saeedi F
AU - Sahebazzamani M
AU - Sahebkar A
AU - Shahabi S
AU - Sharifirad J
AU - Sheikhbahaei S
AU - Shirkoohi R
AU - Shobeiri P
AU - Valizadeh R
AU - Zare I
AU - Tavangar SM
AU - Jamshidi H
AU - Mokdad AH
AU - Naghavi M
AU - Farzadfar F
AU - Larijani B
AU - Mokdad AH
AU - Naghavi M
TI - National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019
JO - Scientific Reports
VL - 12
IS - 1
SP -
EP -
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract